In a letter to the New England Journal of Medicine, a Massachusetts General Hospital (MGH) research team reports a remarkable treatment response in a patient participating in a clinical trial of a novel immune-system-based cancer therapy. Treatment with an investigational... Continue Reading →
Two infants with leukemia are now in remission, thanks to a world-first treatment that uses genetically engineered T-cells from healthy donors. The UK patients were first given the treatment back in 2015, after chemotherapy failed to show results. Now, after... Continue Reading →